Federated Hermes, Inc. Arcturus Therapeutics Holdings Inc. Transaction History
Federated Hermes, Inc.
- $43.6 Billion
- Q3 2024
A detailed history of Federated Hermes, Inc. transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 4,694,060 shares of ARCT stock, worth $77.5 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
4,694,060
Previous 4,694,060
-0.0%
Holding current value
$77.5 Million
Previous $114 Million
4.68%
% of portfolio
0.25%
Previous 0.28%
Shares
15 transactions
Others Institutions Holding ARCT
# of Institutions
179Shares Held
25.6MCall Options Held
195KPut Options Held
133K-
Black Rock Inc. New York, NY2.65MShares$43.7 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.32MShares$38.2 Million0.62% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.28MShares$37.6 Million0.04% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.1MShares$34.7 Million0.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.58MShares$26 Million0.0% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $439M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...